Dermatological Therapeutics Market cover

Dermatological Therapeutics Market by Applications (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Others), Drugs Class (Anti-infective, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoid, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: MC-2494
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 194
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global dermatological therapeutics market size is projected to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to increasing aging population, rising prevalence of skin diseases, and increasing disposable income in developing countries.


Dermatological Therapeutics Market summary

Dermatology is a field of medicine that specializes in the diagnosis, prevention, and treatment of various conditions related to skin, nails, and hair, such as pigmentation, acne, wrinkles, and psoriasis. Dermatological agents, also known as dermatological products, are applied topically to the skin. In addition, these drugs are used to treat various skin conditions such as acne, dermatitis, psoriasis, eczema, and acne.

The Covid-19 pandemic affected the demand and supply of global dermatological therapeutics market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing incidence of dermatological diseases is expected to boost the market during the forecast period.
  • Rapid growth of the healthcare industry owing to rising footfall in dermatologic clinics and increasing expenditure on personal care is major factors fueling the market in the coming years.
  • Growing geriatric population and rising demand for rapid diagnosis, in addition to the surge in skin cancer diseases is anticipated to drive the market during the forecast period.
  • High cost of dermatological treatment and stringent regulations by government on drugs due to certain side effects is projected to restrict the market growth.
  • Lack of awareness among people about new treatment techniques and drugs in market act as major challenges that can hamper the market growth during the forecast period.
  • R&D investment and innovation of new products and increasing merger & acquisition by vendors is expected to offer significant opportunities for the market players.

Scope of the Report

The report on the global dermatological therapeutics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Dermatological Therapeutics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Applications (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Others), and Drugs Class (Anti-infective, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoid, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Almirall SA; Amgen Inc.; Novartis AG; Bausch Health Companies Inc.; and AbbVie Inc.

Market Segment Insights

The psoriasis segment is projected to account for a major market share

In terms of applications, the dermatological therapeutic market is divided into alopecia, herpes, psoriasis, rosacea, atopic dermatitis, and others. The psoriasis segment is expected to represent a key share of the market during the forecast period. Psoriasis is a chronic autoimmune skin disease that accelerates the growth cycle of skin cells and causes thick red and silvery patches of skin on the elbows, face, palms, knees, scalp, lower back, and soles of the feet. The most common form of psoriasis is plaque psoriasis, which is caused by an abnormal attack by the T cells of the skin.

The retinoid segment is expected to grow at a significant pace

Based on drug class, the dermatological therapeutics market is segregated into anti-infective, corticosteroids, anti-acne, calcineurin inhibitors, retinoid, and others. The retinoid segment is expected to hold a key share of the market in the coming years. Retinoid are a type of vitamin A derivative that has been used in skin care since the 1970s. It plays an important role in acne treatment by targeting primary microscopic lesions. They also treat oil production by slowing the growth of bacteria that cause acne and inflammation. On the other hand, the corticosteroids segment is anticipated to expand at a rapid pace during the forecast period. Corticosteroids are known as a cortisone-like drug that is used as a pain reliever to reduce inflammation in the body. These medicines are known to have effects such as reducing itching, swelling, allergic reactions and redness.


Dermatological Therapeutics Market type

 North America is anticipated to dominate the market

On the basis of regions, the dermatological therapeutics market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the forecast period. The regional market growth can be attributed to rising healthcare spending, growing awareness of skin diseases, and a strong presence of pharmaceutical companies.


Dermatological Therapeutics Market region

Segments

Segments Covered in the Report

The global dermatological therapeutics market has been segmented on the basis of

Applications

  • Alopecia
  • Herpes
  • Psoriasis
  • Rosacea
  • Atopic Dermatitis
  • Others

Drugs Class

  • Anti-infective
  • Corticosteroids
  • Anti-acne
  • Calcineurin Inhibitors
  • Retinoid
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Almirall SA
  • Amgen Inc.
  • Novartis AG
  • Bausch Health Companies Inc.
  • AbbVie Inc.

Competitive Landscape

Key players competing in the dermatological therapeutics market include Almirall SA; Amgen Inc.; Novartis AG; Bausch Health Companies Inc.; and AbbVie Inc.
Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.

Dermatological Therapeutics Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Dermatological Therapeutics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Dermatological Therapeutics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Dermatological Therapeutics Market - Supply Chain
  4.5. Global Dermatological Therapeutics Market Forecast
     4.5.1. Dermatological Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Dermatological Therapeutics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Dermatological Therapeutics Market Absolute $ Opportunity
5. Global Dermatological Therapeutics Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Dermatological Therapeutics Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Dermatological Therapeutics Demand Share Forecast, 2019-2026
6. North America Dermatological Therapeutics Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Dermatological Therapeutics Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Dermatological Therapeutics Demand Share Forecast, 2019-2026
7. Latin America Dermatological Therapeutics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Dermatological Therapeutics Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Dermatological Therapeutics Demand Share Forecast, 2019-2026
8. Europe Dermatological Therapeutics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Dermatological Therapeutics Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Dermatological Therapeutics Demand Share Forecast, 2019-2026
9. Asia Pacific Dermatological Therapeutics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Dermatological Therapeutics Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Dermatological Therapeutics Demand Share Forecast, 2019-2026
10. Middle East & Africa Dermatological Therapeutics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Dermatological Therapeutics Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Dermatological Therapeutics Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Dermatological Therapeutics Market: Market Share Analysis
  11.2. Dermatological Therapeutics Distributors and Customers
  11.3. Dermatological Therapeutics Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Almirall SA
     11.4.2. Amgen Inc.
     11.4.3. Novartis AG
     11.4.4. Bausch Health Companies Inc.
     11.4.5. AbbVie Inc.

Segments Covered in the Report

The global dermatological therapeutics market has been segmented on the basis of

Applications

  • Alopecia
  • Herpes
  • Psoriasis
  • Rosacea
  • Atopic Dermatitis
  • Others

Drugs Class

  • Anti-infective
  • Corticosteroids
  • Anti-acne
  • Calcineurin Inhibitors
  • Retinoid
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Almirall SA
  • Amgen Inc.
  • Novartis AG
  • Bausch Health Companies Inc.
  • AbbVie Inc.

Key players competing in the dermatological therapeutics market include Almirall SA; Amgen Inc.; Novartis AG; Bausch Health Companies Inc.; and AbbVie Inc.
Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.

Dermatological Therapeutics Market keyplayers

Buy Report